Compare MobilEye Global Inc (MBLY) vs Morgan Stanley (MS) Price & Performance

Mobileye (MBLY) trades at $8.95, down 2.93% on the day, with a bearish technical signal and mixed earnings history. The company reported a net loss of $392 million in 2025 despite revenue of $1.89 billion, reflecting negative profit margins. Recent news highlights its strategic shift toward launching a vertically integrated U.S. robotaxi service in 2027, generating significant media attention and analyst coverage.

The outlook hinges on execution of its robotaxi initiative, offering growth potential but carrying high execution risk. Analyst consensus is bullish with a $10.71 price target, yet profitability challenges and competitive pressures pose substantial risks. Investors should weigh the long-term transformation against current financial weakness.

Morgan Stanley (MS) trades at $210.97, down 2.09% over the past day, with a bullish technical signal from moving averages and a consensus analyst price target of $241.36. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $3.46 surpassing estimates of $2.89. Revenue growth accelerated to $66.0 billion in 2025, up from $57.6 billion in 2024, while net income margin improved to 25.56%. Recent developments include leading Anthropic's upcoming IPO and expanding AI integration in wealth management services.

The outlook remains positive given strong earnings momentum, analyst bullishness, and strategic initiatives in high-growth areas like AI and IPO advisory. Key risks include volatile cash flows from operations, rising debt levels, and sensitivity to financial market conditions. The stock offers potential upside to analyst targets but requires monitoring of operational cash generation and macroeconomic headwinds affecting the financial sector.